Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data

Retrieved on: 2024-04-08 19:35:42

Tags for this article:

Click the tags to see associated articles and topics

Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data. View article details on hiswai:

Excerpt

Alnylam Pharmaceuticals and its partner Roche Holdings AG (OTC:RHHBY) have initiated a Phase 2 KARDIA-3 study of zilebesiran on top of 2-4 anti ...

Article found on: markets.businessinsider.com